RSS

chimeric antigen receptor (CAR)

A recently published preliminary study involving primates has revealed that a form of engineered stem cell-derived chimeric antigen receptor (CAR) T-cells may be useful in the long-term suppression of HIV. Read more

News

Clinical-stage biopharmaceutical company, Autolus, has announced the publication of pre-clinical data of a novel, dual-targeted, proliferating-inducing ligand (APRIL) chimeric antigen receptor (CAR) for the treatment of multiple myeloma. Read more

News

A biotechnology company, TxCell, Inserm Transfert and Nantes University have signed a R&D collaboration agreement for the development of chimeric antigen receptor (CAR) engineered CD8+Treg cells (CAR-Tregs). Read more

News